TLRY 0.99 (-5.71%)
US88688T1007Drug ManufacturersDrug Manufacturers - Specialty & Generic

Tilray Brands (TLRY) Competitor Comparison

We are evaluating the key criteria listed to compare Tilray Brands (TLRY) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 10 years - TLRY ranking 32 / 54

These are the competitors of Tilray Brands in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 10 years
1. Theratechnologies THTX
73.77
2. ANI Pharmaceuticals ANIP
29.39
3. ProPhase Labs PRPH
14.25
4. Green Thumb Industries R9U2.F
14.08
5. Phibro Animal Health PAHC
9.35
6. Eagle Pharmaceuticals EGRX
9.12
7. Evolus EOLS
9
8. Alimera Sciences ALIM
7.61
9. Vifor Pharma G2AB.F
7.23
10. Regencell Bioscience Holdings RGC
6.69
11. Alvotech ALVO
6.22
12. Linc LNC
5.97
13. Emergent BioSolutions EBS
5.87
14. PetIQ PETQ
5.4
15. Kolinpharma KIP.MI
4.84
16. Avadel Pharmaceuticals AVDL
4.53
17. Societal CDMO SCTL
3.72
18. Ayr Wellness 3KJB.F
3.68
19. Organogenesis Holdings ORGO
3.47
20. Cumberland Pharmaceuticals CPIX
3.34
21. Kamada KMDA
3.23
22. Elanco Animal Health ELAN
3.07
23. Amneal Pharmaceuticals AMRX
3.01
24. Ironwood Pharmaceuticals IRWD
3
25. Curaleaf Holdings CURLF
2.89
26. Taro Pharmaceutical Industries TARO
2.87
27. Embecta EMBC
2.75
28. Cronos Group CRON
2.63
29. Procaps Group PROC
2.57
30. Journey Medical DERM
2.44
31. Neoleukin Therapeutics NLTX
2.29
32. Tilray Brands TLRY
2.27
33. Catalent CTLT
2.12
34. Pacira BioSciences PCRX
2.12
35. Teva Pharmaceutical Industries TEVA
2.11
36. Perrigo PRGO
2.06
37. Alpha Teknova TKNO
1.98
38. Jupiter Wellness JUPW
1.84
39. Biofrontera BFRI
1.78
40. Flora Growth FLGC
1.77
41. Ascend Wellness Holdings AAWH
1.76
42. OptiNose OPTN
1.72
43. Zynerba Pharmaceuticals ZYNE
1.63
44. Clever Leaves Holdings CLVR
1.62
45. Solid Biosciences SLDB
1.59
46. Universe Pharmaceuticals UPC
1.58
47. Relmada Therapeutics RLMD
1.55
48. Bausch Health Companies BHC
1.45
49. SCYNEXIS SCYX
1.37
50. Amphastar Pharmaceuticals AMPH
1.26
51. Collegium Pharmaceutical COLL
1.12
52. Supernus Pharmaceuticals SUPN
1
53. Zoetis ZTS
0.92
54. Harrow Health HROW
0.51

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.